NEU 0.15% $13.13 neuren pharmaceuticals limited

Share Price, page-3772

  1. 597 Posts.
    lightbulb Created with Sketch. 326

    Thanks Hottod, if we add that Menarini had ok FDA with priority rewiew on August 11, 2022 (one month before us) with PDUFA on February 17 (today) and then it was approved in advance on January 30, 2023 and 'really everything possible, we could be approved today, remember that Monday WS is closed:


    https://www.prnewswire.com/news-rel...ed-or-metastatic-breast-cancer-301604240.html


    https://www.menarini.com/en-us/news...ly-indicated-for-patients-with-esr1-mutations
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.